"Vitamin K" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lipid cofactor that is required for normal blood clotting. Several forms of vitamin K have been identified: VITAMIN K 1 (phytomenadione) derived from plants, VITAMIN K 2 (menaquinone) from bacteria, and synthetic naphthoquinone provitamins, VITAMIN K 3 (menadione). Vitamin K 3 provitamins, after being alkylated in vivo, exhibit the antifibrinolytic activity of vitamin K. Green leafy vegetables, liver, cheese, butter, and egg yolk are good sources of vitamin K.
| Descriptor ID |
D014812
|
| MeSH Number(s) |
D02.455.426.559.847.638.721.374 D02.455.849.291.523.500 D04.615.638.721.374
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vitamin K".
Below are MeSH descriptors whose meaning is more specific than "Vitamin K".
This graph shows the total number of publications written about "Vitamin K" by people in this website by year, and whether "Vitamin K" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 1 | 1 | 2 |
| 1998 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 0 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 4 | 0 | 4 |
| 2017 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 4 | 5 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitamin K" by people in Profiles.
-
Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians. Expert Rev Cardiovasc Ther. 2024 Sep; 22(9):483-491.
-
Apixaban for Prevention of Thromboembolism in Pediatric Heart?Disease. J Am Coll Cardiol. 2023 12 12; 82(24):2296-2309.
-
Unleashing ferroptosis for cancer therapy with warfarin. Trends Endocrinol Metab. 2023 11; 34(11):683-684.
-
In thrombotic antiphospholipid syndrome, DOACs vs. VKAs increase arterial thrombotic events but not major bleeding. Ann Intern Med. 2023 04; 176(4):JC43.
-
B-complex vitamins for patients with TANGO2-deficiency disorder. J Inherit Metab Dis. 2023 03; 46(2):161-162.
-
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022 10 11; 146(15):e205-e223.
-
Why Too Many Vitamins Feels Just About Right. JAMA Intern Med. 2022 08 01; 182(8):791-792.
-
Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review. Support Care Cancer. 2022 Oct; 30(10):8539-8545.
-
Anticoagulation and bleeding in the cancer patient. Support Care Cancer. 2022 Oct; 30(10):8547-8557.
-
Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease. Int J Environ Res Public Health. 2022 01 27; 19(3).